Elsevier

Neuropharmacology

Volume 35, Issue 1, January 1996, Pages 63-70
Neuropharmacology

[3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments

https://doi.org/10.1016/0028-3908(95)00134-4Get rights and content

Abstract

Nisoxetine is a potent and selective inhibitor of noradrenaline uptake into noradrenergic neurones. [3H]Nisoxetine binding to rat frontal cortical membranes was of high affinity. The binding data of both competition and saturation studies fitted a single site binding model. [3H]Nisoxetine binding was potently inhibited by the selective noradrenaline uptake inhibitors desipramine and protriptyline. In addition, a very good correlation was obtained between the ability of 25 monoamine reuptake inhibitors and related compounds both to inhibit [3H]nisoxetine binding and to inhibit [3H]noradrenaline uptake in rat frontal cortex. DSP-4 (10–100 mg/kg, i.p.) dose-dependently depleted cortical noradrenaline concentrations (51–100%), with no significant effects on 5-HT and dopamine. These depletions, which were used as a marker of loss of noradrenergic nerve terminals, were associated with a dose-dependent decrease in the number of [3H]nisoxetine binding sites (20–97%) with no change in binding affinity. Furthermore, a good correlation was obtained between cortical noradrenaline concentrations and the number of [3H]nisoxetine binding sites. These data support the view that [3H]nisoxetine binds to a single population of homogeneous sites associated with the noradrenaline transporter complex. Using this ligand, the effects of repeated administration of both antidepressant drugs with a range of pharmacological actions and of electroconvulsive shock on noradrenaline reuptake sites were examined. The number and affinity of [3H]nisoxetine binding sites were unaltered by all treatments. It is unlikely, therefore, that antidepressant therapy would produce adaptive changes in noradrenaline uptake sites.

References (35)

  • G. Racagni et al.

    Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions

    Neuropharmacology

    (1983)
  • M. Rehavi et al.

    ‘High affinity’ binding of [3H]desipramine to rat cerebral cortex: relationship to tricyclic antidepressant-induced inhibition of norepinephrine uptake

    Eur. J. Pharmac.

    (1981)
  • E. Richelson et al.

    Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

    Eur. J. Pharmac.

    (1984)
  • S.M. Tejani-Butt et al.

    [3H]Nisoxetine: a new radioligand for norepinephrine uptake sites in brain

    Eur. J. Pharmac.

    (1990)
  • D.T. Wong et al.

    Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain

    Biochem. Pharmac.

    (1976)
  • I.T. Bäckström et al.

    High- and low-affinity [3H]desipramine-binding sites in human postmortem brain tissue

    Neuropsychobiology

    (1990)
  • I.T. Bäckström et al.

    [3H]Desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons

    J. Neurochem.

    (1989)
  • Cited by (0)

    View full text